Skip to content
Clinical Trials – home
Reade revalidatie & reumatologie centrum te Amsterdam
Sponsor

Reade revalidatie & reumatologie centrum te Amsterdam

The Netherlands Admiraal Helfrichstraat 1, 1056 AA Amsterdam, The Netherlands

About the sponsor

The clinical research activity centres on rheumatoid arthritis, with studies focused on patients diagnosed according to established ACR/EULAR criteria. The sponsor’s trial portfolio reflects a strong interest in disease control, symptom burden, and treatment optimisation in chronic inflammatory arthritis.

  • Rheumatoid arthritis
  • Disease Activity Score in 28 joints (DAS28-ESR)
  • Inflammatory arthritis

Research activity includes treatment adjustment strategies aimed at maintaining control of joint inflammation while improving long-term management of RA.

About Specializations

Reade revalidatie & reumatologie centrum te Amsterdam runs clinical trials in conditions such as Rheumatoid arthritis, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Tocilizumab
  • Sponsor:Reade revalidatie & reumatologie centrum te Amsterdam
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Filgotinib
  • Sponsor:Reade revalidatie & reumatologie centrum te Amsterdam

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.